CIPLA TADALAFIL 5 tadalafil 5 mg film-coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

tadalafil, Quantity: 5 mg

Disponible depuis:

Cipla Australia Pty Ltd

DCI (Dénomination commune internationale):

Tadalafil

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: lactose monohydrate; sodium lauryl sulfate; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; hyprolose; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red

Mode d'administration:

Oral

Unités en paquet:

28, 7, 20, 10

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

CIPLA TADALAFIL is indicated for the treatment of: ? erectile dysfunction (ED) in adult males ? moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males

Descriptif du produit:

Visual Identification: Cream coloured, circular, biconvex film coated tablet with "T 5" debossed on one side and plain on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2017-03-27